Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.71 |
| ▸ | TP53 | P04637 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.71 |
| ▸ | CETP | P11597 | 7/20 | 0.68 |
| ▸ | MEN1 | O00255 | 4/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | THRB | P10828 | 3/20 | 0.68 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.67 |
| ▸ | ASAH2 | Q9NR71 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.50 |
| ▸ | GMNN | O75496 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12795857 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL31003583 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL10001355 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL6661598 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL12994189 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL1976275 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL4140908 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL12316166 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL4133159 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 | |
| SCHEMBL30652483 | 1.00 | MAPT (0.71) | MAPTCYP2D6MAPK1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3086767-B1 | PROCESS FOR TREATING KERATIN FIBRES WITH AN OXIDISED POLYSACCHARIDE AND A SPHINGOSINE COMPOUND | OREAL (FR) | 2018-06-13 | — | — | EP | claimed |
| US-11730682-B2 | Self-standing cosmetic sheet | L'OREAL (FR) | 2023-08-22 | — | — | US | disclosed |
| EP-2836187-B1 | SELF-STANDING COSMETIC SHEET | OREAL (FR) | 2021-12-08 | — | — | EP | disclosed |
| EP-2198849-B2 | Composition for oxidising dyeing of keratinous fibres | OREAL (FR) | 2020-11-11 | — | — | EP | disclosed |
| US-20180235849-A1 | SELF-STANDING COSMETIC SHEET | L'OREAL (FR) | 2018-08-23 | — | — | US | disclosed |
| US-9949897-B2 | Self-standing cosmetic sheet | L'OREAL (FR) | 2018-04-24 | — | — | US | disclosed |
| US-20150209243-A1 | SELF-STANDING COSMETIC SHEET | L'OREAL (FR) | 2015-07-30 | — | — | US | disclosed |
| EP-2836187-A1 | SELF-STANDING COSMETIC SHEET | L'Oréal (FR) | 2015-02-18 | — | — | EP | disclosed |
| WO-2013153678-A1 | SELF-STANDING COSMETIC SHEET | L'OREAL (FR) | 2013-10-17 | — | — | WO | disclosed |
| US-8268805-B2 | Use of ceramides for depigmenting the skin | L'OREAL (FR) | 2012-09-18 | — | — | US | disclosed |
| US-20090192124-A1 | USE OF CERAMIDES FOR DEPIGMENTING THE SKIN | L'OREAL (FR) | 2009-07-30 | — | — | US | disclosed |
| WO-2008015366-A2 | cosmetic treatment process comprising the application of an anhydrous composition in the form of a water-soluble film in the presence of a fluid comprising water vapour | L'OREAL (FR) | 2008-02-07 | — | — | WO | disclosed |
| WO-2008015367-A2 | COSMETIC TREATMENT PROCESS USING AN ANHYDROUS COMPOSITION IN THE FORM OF A FILM COMPRISING A FILM-FORMING POLYMER AND A CONDITIONING AGENT | L'OREAL (FR) | 2008-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150209243-A1 | SELF-STANDING COSMETIC SHEET | CUTA, SUCLG1, SIGLEC7 | MAPT 4402/4885CYP2D6 4653/4885MAPK1 3932/4885 |
| US-20180235849-A1 | SELF-STANDING COSMETIC SHEET | CUTA, DSG1, SUCLG1 | MAPT 3846/4885CYP2D6 4100/4885MAPK1 3774/4885 |
| US-20090192124-A1 | USE OF CERAMIDES FOR DEPIGMENTING THE SKIN | CERS2, CERT1, ASAH2 | MAPT 3244/4885CYP2D6 2906/4885MAPK1 1578/4885 |
| US-11730682-B2 | Self-standing cosmetic sheet | CUTA, DSG1, SUCLG1 | MAPT 3846/4885CYP2D6 4100/4885MAPK1 3774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.